Clinical Trial Update: Bacteriophage Clinical Trial for Periprosthetic Joint Infection of Multidrug Resistant Pseudomonas Aeruginosa

View source ↗

Summary

An update on an ongoing clinical trial evaluating bacteriophage therapy for periprosthetic joint infection caused by multidrug-resistant Pseudomonas aeruginosa;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periprosthetic Joint Infection

Drugs mentioned

• Bacteriophage therapy

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Joint Infection | Status: AVAILABLE